Debra Zack

Debra Zack

Director Técnico/Científico/I+D en SPERO THERAPEUTICS, INC. .

Fortuna: 189 904 $ al 31/07/2026

69 años
Health Technology
Consumer Services
Health Services

Perfil

Debra Jeske Zack is currently Chief Medical Officer at Spero Therapeutics, Inc. since 2026.
Former positions include Chief Medical Officer at Exagen, Inc. from 2020 to 2022, Executive Director-Global Product Area at Amgen, Inc., Vice President-Clinical Development at Xencor, Inc., and Associate Professor at the University of California, Los Angeles.
Education includes undergraduate studies at Texas Christian University and a doctorate from The University of Texas Southwestern Medical Center.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
03/08/2026 162.311 ( 0,28 % ) 189 904 $ 31/07/2026

Cargos activos de Debra Zack

EmpresasCargoInicio
SPERO THERAPEUTICS, INC. Director Técnico/Científico/I+D 27/07/2026

Antiguos cargos conocidos de Debra Zack.

EmpresasCargoFin
EXAGEN INC. Director Técnico/Científico/I+D 05/12/2022
Corporate Officer/Principal -
AMGEN INC. Corporate Officer/Principal -
XENCOR, INC. Corporate Officer/Principal -
Ver el detalle de la experiencia de Debra Zack.

Formación de Debra Zack.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

22

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Services

Consumer Services

Health Technology